Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak
JAMA Network Open · 14.11.2025 · 8 (11) · e2543002
DOI: 10.1001/jamanetworkopen.2025.43002 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 14.11.2025. Verfasst von Brianna M Goodwin Cartwright und 5 weiteren Autor:innen. Beteiligte Einrichtung: Truveta Inc, Bellevue, Washington. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
This cross-sectional study examines early vaccination rates for measles in Texas following updated 2025 guidance from the US Centers for Disease Control and Prevention.
Autor:innen und Institutionen
- Truveta Inc, Bellevue, Washington.
Zitieren
APA
Goodwin Cartwright, B. M., Masters, N. B., Gilbert, K. M., Rodriguez, P. J., Do, D., & Stucky, N. (2025). Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak. JAMA Network Open, 8(11), e2543002. https://doi.org/10.1001/jamanetworkopen.2025.43002
Vancouver
Goodwin Cartwright BM, Masters NB, Gilbert KM, Rodriguez PJ, Do D, Stucky N. Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak. JAMA Network Open. 2025;8(11):e2543002. doi:10.1001/jamanetworkopen.2025.43002
BibTeX
@article{GoodwinCartwright2025,
author = {Goodwin Cartwright, Brianna M and Masters, Nina B and Gilbert, Karen M and Rodriguez, Patricia J and Do, Duy and Stucky, Nicholas},
title = {Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {11},
pages = {e2543002},
doi = {10.1001/jamanetworkopen.2025.43002}
}
EUVIMED